Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com

Barron'sJan 9 00:58

Bernstein Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $310

Futu NewsJan 8 01:32 · Ratings

Alnylam Pharmaceuticals Is Maintained at Outperform by Bernstein

Dow JonesJan 8 01:29 · Ratings

Alnylam Pharmaceuticals Analyst Ratings

BenzingaJan 8 01:16 · Ratings

Express News | Alnylam Pharmaceuticals Inc : Bernstein Cuts Target Price to $310 From $314

BreakingsJan 7 16:39

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

BenzingaJan 4 02:08